<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="GBP" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>GB-GOV-13-FUND--GCRF-MR_V028537_1</iati-identifier>
  <reporting-org ref="GB-GOV-13" type="10">
   <narrative xml:lang="EN">Department of Business, Energy and Industrial Strategy</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Measuring unanticipated opportunity costs of South Africa&apos;s COVID-19 response for children, mothers, and people living with non-communicable diseases</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">Aims to measure the impact of redirecting resources from routine health services and seeks to understand the perspective of health workers and communities about this repositioning of services.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">The SA government introduced a strict lockdown in response to the COVID-19 epidemic, providing extra hospital beds and widespread community testing and tracing. At the same time, SA has high levels of HIV (the highest number globally), Tuberculosis, undernutrition, obesity, Diabetes, and Hypertension as well as excessive levels of violence and trauma. By focusing only on COVID-19, providing the usual preventive and curative health services may have suffered. The fast response has reduced the voice of communities in decision-making. People stop attending health services either because of fear or because of temporary unavailability of services. This may have consequences for the health of women and children and people who live with chronic conditions. Our study aims to measure the impact of redirecting resources from routine health services and seeks to understand the perspective of health workers and communities about this repositioning of services.  The project will focus on mother and child health, and on people with hypertension and diabetes, diseases that result in significant sickness and death. These analyses will shift the needle from assumptions to reality and show where the most lives are being lost, many of them not COVID-19 related. This can and will inform policy decisions for current and future epidemics.</narrative>
  </description>
  <participating-org ref="GB-GOV-13" role="1" type="10">
   <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
  </participating-org>
  <participating-org role="3" type="90">
   <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">Wits Health Consortium (Pty) Ltd</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-09-14" type="1"></activity-date>
  <activity-date iso-date="2020-10-01" type="2"></activity-date>
  <activity-date iso-date="2022-03-13" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">International Development</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">GCRF</narrative>
   </person-name>
   <email>gcrf@ukri.org</email>
   <website>https://www.ukri.org/</website>
   <mailing-address>
    <narrative xml:lang="EN">Polaris House, Swindon, SN2 1LF</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="ZA" percentage="100">
   <narrative xml:lang="EN">South Africa</narrative>
  </recipient-country>
  <recipient-region code="1029" percentage="100" vocabulary="1"></recipient-region>
  <sector code="43082" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research/scientific institutions</narrative>
  </sector>
  <tag code="RI" vocabulary="99" vocabulary-uri="https://devtracker.fcdo.gov.uk/custom-codes">
   <narrative xml:lang="EN">Research and Innovation</narrative>
  </tag>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="GBP" value-date="2020-09-15">237659.32</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="GBP" value-date="2020-09-15">445961.14</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-15"></transaction-date>
   <value currency="GBP" value-date="2020-09-15">683620.46</value>
   <description>
    <narrative xml:lang="EN">MRC GCRF Research Grants Award to Wits Health Consortium (Pty) Ltd</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR/V028537/1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK Research &amp; Innovation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-01"></transaction-date>
   <value currency="GBP" value-date="2020-10-01">118829.66</value>
   <description>
    <narrative xml:lang="EN">Quarterly Payment for the GCRF funded activity</narrative>
   </description>
   <provider-org provider-activity-id="GB-GOV-13-FUND--GCRF-MR_V028537_1" ref="GB-GOV-13">
    <narrative xml:lang="EN">UK - Department for Business, Energy and Industrial Strategy</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Wits Health Consortium (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/HTTP" url="http://gtr.rcuk.ac.uk/projects?ref=MR%2FV028537%2F1">
   <title>
    <narrative xml:lang="EN">Abstract/Planned Impact</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-10-01"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.ukri.org/funding/information-for-award-holders/grant-terms-and-conditions/">
   <title>
    <narrative xml:lang="EN">UK Research &amp; Innovation Grant Terms and Conditions</narrative>
   </title>
   <category code="A04"></category>
  </document-link>
  <conditions attached="1"></conditions>
 </iati-activity>
</iati-activities>
